Extended Data Fig. 5: Fraction of neutralizers in the cohorts of vaccinated or convalescent individuals.

Individuals with an ED50 of neutralization above 30 were categorized as neutralizers and are indicated in pink. Non-neutralizers are in grey. The numbers indicate the percentage of neutralizers. a. Fraction of neutralizers in sera from Pfizer (n = 16) (left panel) and AstraZeneca (n = 18) (right panel) vaccinated recipients sampled 5 months after the second dose (results related to Fig. 2a). b. Fraction of neutralizers in sera from Pfizer vaccinated recipients sampled one month after the 3^rd injection (n = 20; (results related to Fig. 2b). c. Fraction of neutralizers in sera from convalescent individuals, sampled at 6 months post onset of symptoms (M6) (n = 16) (right panel), at 12 months (M12) (n = 23) (middle panel) and one month after the 1^st injection (n = 22) (right panel; results related to Fig. 2c). In each panel, data are mean from 2 to 3 independent experiments.